Feds Case for Rate Cuts Diminishes as Jobs Report Highlights Persistent Cost of Living Pressures Nvidias Growth Story Shifts Reasons Behind Wall Streets Cautious Turn SPIC Reports Higher Q4 Profit on Improved Cost Management FullYear Net Income Rises Indian Equity Markets Wobbly Hind Zinc SBI Force Motors Among Most Active Stocks Crude Oil Futures Maintain Upward Momentum Amid Supply Concerns QXO Launches Hostile Takeover Bid for Beacon After Repeated Rejections XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges FCRX Q1 2026 Earnings Slight EPS Miss Reflects Stable but Unspectacular Quarter JCI Q1 2026 Earnings Earnings Beat Estimates as Operational Efficiency Drives Margin Improvement NXPI Q1 2026 Earnings EPS Surpasses Estimates Stock Rallies 57 AEP Q1 2026 Earnings EPS Beat Surprises Shares Edge Higher Mercantile Bank Corporation MBWM Edges Lower as Shares Test Key Support Levels Calisa Acquisition Corp Right ALISR Holds Steady at 056 Amid Low Volume Consolidation Delta Air Lines DAL Rallies 3 as Air Travel Demand Strengthens BHFAP Preferred Shares Edge Lower Amid Narrow Trading Range Crescent Capital BDC CCAP Edges Higher Navigating Support and Resistance Levels Jackson Financial Inc JXN Edges Higher as Shares Test Key Resistance at 10827 Estate Planning Dilemma Cashing Out CDs During Hospice Care CACC Q1 2026 Earnings EPS Slightly Below Estimates as Subprime Trends Persist China Tungsten Exports to Japan Halve Amid Stricter Export Controls Trump Delays AI Executive Order Signing Cites Concerns Over Potential Restrictions AMBP Q1 2026 Earnings Strong EPS Beat of 127 Surprise Amid Stock Decline Franklin Resources BEN Edges Higher Amid Modest Gains Key Levels to Watch EME Q1 2026 Earnings Strong EPS Surprise of 1487 Drives Attention but Stock Slips authID Q1 2026 Earnings Net Loss of 028 Per Share as Stock Rises 24 EOSE Q1 2026 Earnings Adjusted Loss Narrows as EPS Surprises to the Upside EVER Q1 2026 Earnings EPS Surprises to the Upside Stock Gains 275 FSTR Q1 2026 Earnings Surprise EPS Profit Beats Estimates by Wide Margin ArriVent BioPharma Inc Q1 2026 Earnings Clinical Progress Overrides EPS Miss as Shares Surge TransAlta Q1 2026 Earnings EPS Slightly Misses Estimates Amid Marginal Stock Gain